KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Return on Invested Capital (2017 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Return on Invested Capital for 15 consecutive years, with 0.05% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 2.0% year-over-year to 0.05%, compared with a TTM value of 0.05% through Dec 2025, down 2.0%, and an annual FY2025 reading of 0.05%, down 2.0% over the prior year.
  • Return on Invested Capital was 0.05% for Q4 2025 at Biomarin Pharmaceutical, down from 0.08% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.2% in Q2 2021 and bottomed at 0.02% in Q4 2021.
  • Average Return on Invested Capital over 5 years is 0.05%, with a median of 0.03% recorded in 2022.
  • Peak annual rise in Return on Invested Capital hit 16bps in 2021, while the deepest fall reached -19bps in 2021.
  • Year by year, Return on Invested Capital stood at 0.02% in 2021, then soared by 304bps to 0.03% in 2022, then dropped by -1bps to 0.03% in 2023, then skyrocketed by 110bps to 0.07% in 2024, then dropped by -29bps to 0.05% in 2025.
  • Business Quant data shows Return on Invested Capital for BMRN at 0.05% in Q4 2025, 0.08% in Q3 2025, and 0.1% in Q2 2025.